E-LIB Suche - Ergebnisse für: D. Hueppe

1

High efficacy of sofosbuvir/velpatasvir and impact of basel..:

von Felden, J. ; Vermehren, J. ; Ingiliz, P....
Alimentary Pharmacology & Therapeutics. 47 (2018) 9 - p. 1288-1295 , 2018

Link: https://doi.org/10.1111/..

2

Effect of eradicating hepatitis C on alanine aminotransfera..:

Mauss, S. ; Boesecke, C. ; Berger, F....
Journal of Hepatology. 66 (2017) 1 - p. S739-S740 , 2017

Link: https://doi.org/10.1016/..

3

Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Rib..:

Christensen, S. ; Ingiliz, P. ; Schewe, K....
Journal of Hepatology. 66 (2017) 1 - p. S739 , 2017

Link: https://doi.org/10.1016/..

4

Long-term follow-up after IFN-free therapy of advanced HCV-..:

Deterding, K. ; Mauss, S. ; Pathil, A....
Journal of Hepatology. 66 (2017) 1 - p. S55 , 2017

Link: https://doi.org/10.1016/..

5

Relapse and Treatment-Emergent RAVS with DAA-Based Regimens..:

Christensen, S. ; Ingiliz, P. ; Schewe, K....
Journal of Hepatology. 64 (2016) 2 - p. S821 , 2016

Link: https://doi.org/10.1016/..

6

Parameters Associated with Treatment Failure with Direct Ac..:

Ingiliz, P. ; Christensen, S. ; Kimhofer, T....
Journal of Hepatology. 64 (2016) 2 - p. S808-S809 , 2016

Link: https://doi.org/10.1016/..

7

P0835 : German multicenter cohort on sofosbuvir-based treat..:

Ingiliz, P. ; Christensen, S. ; Hueppe, D....
Journal of Hepatology. 62 (2015) - p. S650 , 2015

Link: https://doi.org/10.1016/..

8

P0777 : Sofosbuvir-based treatment under real life conditio..:

Buggisch, P. ; Sarrazin, C. ; Mauss, S....
Journal of Hepatology. 62 (2015) - p. S622 , 2015

Link: https://doi.org/10.1016/..

9

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TE..:

Hofmann, W.P. ; Mauss, S. ; Baumgarten, A....
Journal of Hepatology. 60 (2014) 1 - p. S466 , 2014

Link: https://doi.org/10.1016/..

10

O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B ..:

Petersen, J. ; Heyne, R. ; Mauss, S....
Journal of Hepatology. 60 (2014) 1 - p. S51 , 2014

Link: https://doi.org/10.1016/..

11

P1136 TRIPLE THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALF..:

Buggisch, P. ; Schober, A. ; Bruch, H.R....
Journal of Hepatology. 60 (2014) 1 - p. S460-S461 , 2014

Link: https://doi.org/10.1016/..

12

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC ..:

Christensen, S. ; Boeker, K.H.W. ; Eisenbach, C....
Journal of Hepatology. 60 (2014) 1 - p. S465 , 2014

Link: https://doi.org/10.1016/..

13

P1149 PHYSICIAN ADHERENCE TO AND EFFICACY OF TRIPLE THERAPY..:

Mauss, S. ; Schober, A. ; John, C....
Journal of Hepatology. 60 (2014) 1 - p. S465-S466 , 2014

Link: https://doi.org/10.1016/..

14

P1141 SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV TREATMENT..:

Boeker, K.H.W. ; Link, R. ; Baumgarten, A....
Journal of Hepatology. 60 (2014) 1 - p. S462-S463 , 2014

Link: https://doi.org/10.1016/..

15

P1043 REAL-LIFE PERSISTENCE AND ADHERENCE IN ETV TREATED CH..:

Petersen, J. ; Wilke, T. ; Mauss, S....
Journal of Hepatology. 60 (2014) 1 - p. S423 , 2014

Link: https://doi.org/10.1016/..